Gyroscope nets £50.4M to advance dry AMD gene therapy

Gyroscope raised £50.4 million ($61.1 million) in a series B round to accelerate the development of its dry AMD gene therapy and build out its manufacturing capabilities.

The

Read the full 271 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE